Literature DB >> 8207435

In situ hybridization evidence of differential modulation by pentobarbital of GABAA receptor alpha 1- and beta 3-subunit mRNAs.

Y T Tseng1, S E Wellman, I K Ho.   

Abstract

Tolerance to and withdrawal from pentobarbital were induced in rats by continuous intracerebroventricular infusion via subcutaneously implanted osmotic minipumps. In situ hybridization of GABAA receptor alpha 1- and beta 3-subunit mRNA was conducted using synthetic 3'-end 35S-dATP-labeled oligodeoxynucleotide probes. Results were quantified by film densitometry. In animals that were tolerant to pentobarbital, levels of alpha 1-subunit mRNA were decreased in hippocampus, superior colliculus, and inferior colliculus, but levels of beta 3-subunit mRNA were not affected. Dramatically increased levels of GABAA receptor subunit mRNA were observed in animals 24 h after withdrawal from chronic pentobarbital treatment. These increases occurred in cerebral cortex and cerebellum for the alpha 1 subunit and in cerebral cortex only for the beta 3-subunit. These data provide further support to the structural and pharmacological GABAA receptor heterogeneity in discrete brain areas. The observed changes of subunit expression may underlie, at least in part, the receptor up- and down-regulation observed in receptor ligand binding studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207435     DOI: 10.1046/j.1471-4159.1994.63010301.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  An initiator element mediates autologous downregulation of the human type A gamma -aminobutyric acid receptor beta 1 subunit gene.

Authors:  S J Russek; S Bandyopadhyay; D H Farb
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Changes of [3H]muscimol binding and GABA(A) receptor beta2-subunit mRNA level by tolerance to and withdrawal from pentobarbital in rats.

Authors:  S Oh; I K Ho
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

3.  Plasticity in GABAA receptor subunit mRNA expression by hypothalamic magnocellular neurons in the adult rat.

Authors:  V S Fénelon; A E Herbison
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

4.  Changes in [3H]forskolin binding to adenylate cyclase and [3H]phorbol dibutyrate binding to protein kinase C in pentobarbital tolerant/dependent rats.

Authors:  S Oh; S E Wellman; I K Ho
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

5.  Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes.

Authors:  K L Eagleson; M C Gravielle; L J Schlueter McFadyen-Ketchum; S J Russek; D H Farb; P Levitt
Journal:  Neuroscience       Date:  2010-04-07       Impact factor: 3.590

6.  Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression.

Authors:  D S Roberts; Y H Raol; S Bandyopadhyay; I V Lund; E C Budreck; M A Passini; M J Passini; J H Wolfe; A R Brooks-Kayal; S J Russek
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-09       Impact factor: 11.205

7.  Ginsenoside Rc and Rg1 differentially modulate NMDA receptor subunit mRNA levels after intracerebroventricular infusion in rats.

Authors:  H S Kim; S L Hwang; S Oh
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

8.  Modulation of the levels of NMDA receptor subunit mRNA and the bindings of [3H]MK-801 in rat brain by chronic infusion of subtoxic dose of MK-801.

Authors:  S Oh; Y H Kim; H J Hann; H L Lee; H S Choi; H S Kim; I K Ho
Journal:  Neurochem Res       Date:  2001-05       Impact factor: 3.996

Review 9.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

10.  Pharmacological modulation of adrenal medullary GABAA receptor: consistent with its subunit composition.

Authors:  M Parramón; M P González; M J Oset-Gasque
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.